首页 产品目录 分子砌块 按反应类型 烷基化 4-羟基-6-(4-(三氟甲基)苯乙基)哒嗪-3(2H)-酮

4-羟基-6-(4-(三氟甲基)苯乙基)哒嗪-3(2H)-酮

4-Hydroxy-6-(4-(trifluoromethyl)phenethyl)pyridazin-3(2H)-one

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
5mg 99% 询价
- +
10mg 99% 询价
- +
25mg 99% 询价
- +
50mg 99% 询价
- +
100mg 99% 询价
- +
250mg 99% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1425511-32-5

中文名称

4-羟基-6-(4-(三氟甲基)苯乙基)哒嗪-3(2H)-酮

英文名称

4-Hydroxy-6-(4-(trifluoromethyl)phenethyl)pyridazin-3(2H)-one

别名

3(2H)-Pyridazinone, 4-hydroxy-6-[2-[4-(trifluoromethyl)phenyl]ethyl]-;4-Hydroxy-6-{2-[4-(trifluoromethyl)phenyl]ethyl}pyridazin-3(2H)-one;Luvadaxistat (Synonyms: TAK-831);Luvadaxistat;TAK-831;TAK-831|||NBI 1065844;NBI-1065844

标准英文名

6-(4-(trifluoromethyl)phenethyl)-1,2-dihydropyridazine-3,4-dione

分子式

C13H11F3N2O2

分子量

284.24

精确分子量

284.08

SMILES

O=C1C(O)=CC(CCC2=CC=C(C(F)(F)F)C=C2)=NN1

标准SMILES

OC1=CC(CCC2C=CC(=CC=2)C(F)(F)F)=NNC1=O

用途

Luvadaxistat (TAK-831) is a potent, highly selective, and orally active inhibitor of D-amino acid oxidase (DAAO); it inhibits the oxidative deamination of D-serine by human recombinant DAAO with an IC50 of 14 nM; significantly increases D-serine levels in the brain, plasma, and cerebrospinal fluid of rodents; and has potential for the investigation of schizophrenia.

InChIKey

QBQMUMMSYHUDFM-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  1425511-32-5 逆合成路线 1

—
—
—
—
ACVARB709
1425511-32-5
来源: SureRoute

2.  1425511-32-5 逆合成路线 2

—
—
ACVARB709
1425511-32-5
来源: SureRoute

3.  1425511-32-5 逆合成路线 3

—
—
ACVARB709
1425511-32-5
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手